Family Building FEHB Fairness Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill mandates that Federal Employees Health Benefits (FEHB) plans cover comprehensive fertility treatments including IVF, egg/sperm freezing, artificial insemination, genetic testing of embryos, fertility medications. It relies on compliance mandates and product standards. The main policy areas are Healthcare, Finance, and Trade.
Who Benefits and How
Federal employees and dependents seeking fertility treatment could see lower costs, IVF and assisted reproductive technology providers could gain revenue opportunities, and Fertility clinics and reproductive endocrinology practices could gain revenue opportunities.
Who Bears the Burden and How
U.S. Treasury (federal government as employer) could face higher costs, Federal employee health insurance carriers would take on compliance duties, and Office of Personnel Management would take on compliance duties.
Key Provisions
- Mandates that Federal Employees Health Benefits (FEHB) plans cover comprehensive fertility treatments including IVF, egg/sperm freezing, artificial insemination, genetic testing of embryos, fertility medications...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill mandates that Federal Employees Health Benefits (FEHB) plans cover comprehensive fertility treatments including IVF, egg/sperm freezing, artificial insemination, genetic testing of embryos, fertility medications.
Key Policy Areas
Healthcare, Finance, Trade
Primary Purpose
The bill mandates that Federal Employees Health Benefits (FEHB) plans cover comprehensive fertility treatments including IVF, egg/sperm freezing, artificial insemination, genetic testing of embryos, fertility medications.
Policy Domains
Section 2 - Fertility treatment benefits
Identified Gains
- Federal employees and dependents seeking fertility treatment
- IVF and assisted reproductive technology providers
- Fertility clinics and reproductive endocrinology practices
- Pharmaceutical companies producing fertility medications
- Gamete donation services and sperm/egg banks
Identified Costs
- U.S. Treasury (federal government as employer)
- Federal employee health insurance carriers
- Office of Personnel Management
Sponsors
Legislative Progress
In CommitteeMs. Duckworth (for herself, Mr. Welch, Ms. Warren, Mr. Padilla, …
Read twice and referred to the Committee on Homeland Security …
Introduced in Senate
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Cryopreservation facilities (egg/sperm/embryo freezing), Fertility clinics and reproductive endocrinology practices, Gamete donation services and sperm/egg banks
Office of Personnel Management, U.S. Treasury (federal government as employer)
Pharmaceutical companies producing fertility medications
Genetic testing laboratories (embryo testing)
Federal employees and dependents seeking fertility treatment
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_director"
- → Director of the Office of Personnel Management
- "the_secretary"
- → Secretary of Health and Human Services
Key Definitions
Terms defined in this bill
Includes preservation of oocytes/sperm/embryos, artificial insemination, assisted reproductive technology (IVF), genetic testing of embryos, fertility medications, gamete donation, and other related services as determined by OPM Director in coordination with HHS Secretary
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology